Literature DB >> 34011807

[Optimal dose of levodopa-carbidopa intestinal gel in the treatment of diphasic dyskinesia and freezing of gait].

Motoshige Okajima1, Shinsuke Fujioka1, Saori Komorita1, Akihiro Nishida1, Takayasu Mishima1, Yoshio Tsuboi1.   

Abstract

A 58-year-old man who was diagnosed with Parkinson's disease (PD) at age 46 developed levodopa-induced motor complications seven years after diagnosis, along with dyskinesia. Treatment with levodopa-carbidopa intestinal gel (LCIG) was introduced at age 57. His dyskinesia and freezing of gait (FOG) worsened after the introduction of LCIG. Considering the pathophysiological mechanism of diphasic dyskinesia, the dose of levodopa was increased since it was considered necessary to exceed the upper threshold of diphasic dyskinesia. As a result, dyskinesia and FOG became severe and he was admitted to our hospital. After reducing the levodopa equivalent dose to control the dyskinesia to an almost negligible level, his FOG also improved and his activities of daily living improved markedly. This case highlights the difficulty in treating dyskinesia and FOG in advanced-stage PD patients with a narrow therapeutic window.

Entities:  

Keywords:  Parkinson’s disease; dyskinesia; freezing gait; levodopa-carbidopa intestinal gel therapy; wearing off

Mesh:

Substances:

Year:  2021        PMID: 34011807     DOI: 10.5692/clinicalneurol.cn-001537

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  Levodopa-carbidopa intestinal gel therapy may cause "Supra-ON freezing of gate" in patients with Parkinson's disease with diphasic dyskinesia.

Authors:  Saki Oshiro; Toru Baba; Atsushi Takeda
Journal:  eNeurologicalSci       Date:  2021-12-09

Review 2.  Levodopa-Carbidopa Intestinal Gel may improve treatment-resistant freezing of gait in Parkinson's disease.

Authors:  Melanie R Shackleford; Virendra Mishra; Zoltan Mari
Journal:  Clin Park Relat Disord       Date:  2022-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.